Impel NeuroPharma Receives $36,000,000 Series C Financing Round

  • Feed Type
  • Date
    12/6/2016
  • Company Name
    Impel NeuroPharma
  • Mailing Address
    915 East Pine Street Seattle, WA 98122 USA
  • Company Description
    Seattle-based Impel NeuroPharma was founded with a mission to enable drugs to bypass the blood brain barrier.
  • Website
    http://www.impelneuropharma.com
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $36,000,000
  • Transaction Round
    Series C
  • Proceeds Purposes
    The company will use the proceeds to advance its drug delivery platform.
  • M&A Terms
  • Venture Investor
    venBio
  • Venture Investor
    5AM Ventures
  • Venture Investor
    Vivo Capital

Trending on Xconomy